Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma by Nastoupil, Loretta J., Chin, Collin K., Westin, Jason R., Fowler, Nathan H., Samaniego, Felipe, Cheng, Xiaoyun, Ma, Man Chun John, Wang, Zhiqiang, Chu, Fuliang, Dsouza, Ly, Obi, Chizobam, Mims, Jennifer, Feng, Lei, Zhou, Shouhao, Green, Michael, Davis, Richard Eric, Neelapu, Sattva S.

Get full text

Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trialResearch in... by Ashwath Gurumurthi, Collin K. Chin, Lei Feng, Nathan H. Fowler, Paolo Strati, Fredrick B. Hagemeister, Luis E. Fayad, Jason R. Westin, Chizobam Obi, Janine Arafat, Ranjit Nair, Raphael E. Steiner, Sattva S. Neelapu, Christopher R. Flowers, Loretta J. Nastoupil

Get full text

High Complete Response Rates with Pembrolizumab in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma: Results of an Open-Label, Phase II Study by Nastoupil, Loretta, Westin, Jason R., Fowler, Nathan H., Fanale, Michelle A., Samaniego, Felipe, Oki, Yasuhiro, Dsouza, Ly, Obi, Chizobam, Cao, JingJing, Cheng, Xiaoyun, MA, Man Chun John, Zhiqiang, Wang, Feng, Lei, Zhou, Shouhao, Davis, R. Eric, Neelapu, Sattva S.

Get full text

Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trial by Gurumurthi, Ashwath, Chin, Collin K., Feng, Lei, Fowler, Nathan H., Strati, Paolo, Hagemeister, Fredrick B., Fayad, Luis E., Westin, Jason R., Obi, Chizobam, Arafat, Janine, Nair, Ranjit, Steiner, Raphael E., Neelapu, Sattva S., Flowers, Christopher R., Nastoupil, Loretta J.

Get full text